EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Panobinostat Attenuates Experimental Autoimmune Encephalomyelitis in Mice via Suppressing Oxidative Stress-Related Neuroinflammation and Mitochondrial Dysfunction

Yanjia Shen, Jiaying Zhao, Ran Yang, Huilin Yang, Minmin Guo, Baixi Ji, Guanhua Du, Li Li iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252212035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yanjia Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking…. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Panobinostat, Oxidative Stress, Mitochondria. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences, Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is an autoimmune disease mediated by T helper cells, which is characterized by neuroinflammation, axonal or neuronal loss, demyelination, and astrocytic gliosis. Histone deacetylase inhibitors (HDACis) are noted for their roles in easing inflammatory conditions and suppressing the immune response. Panobinostat, an HDACi, is now being used in treating multiple myeloma. Nevertheless, the effect of panobinostat on autoimmune diseases remains largely unclear. Thus, our research endeavored to determine if the administration of panobinostat could prevent experimental autoimmune encephalomyelitis (EAE) in mice, one of the most commonly used animal models of MS, and further explored the underlying mechanisms. The EAE mice were generated and then administered continuously with panobinostat at a dosage of 30 mg/kg for 16 days. The results indicated that panobinostat markedly alleviated the clinical symptoms of EAE mice, inhibiting demyelination and loss of oligodendrocytes in the central nervous system (CNS). Moreover, panobinostat decreased inflammation and the activation of microglia and astrocytes in the spinal cords of EAE mice. Mechanistically, treatment with panobinosat significantly suppressed M1 microglial polarization by blocking the activation of toll-like receptor 2 (TLR2)/myeloid differentiation factor 88 (MyD88)/interferon regulatory factor 5 (IRF5) pathway. Additionally, panobinostat inhibited mitochondrial dysfunction and reduced oxidative stress in the spinal cords of EAE mice. In conclusion, our findings reveal that panobinostat significantly ameliorates experimental autoimmune encephalomyelitis in mice by inhibiting oxidative stress-linked neuroinflammation and mitochondrial dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalPanobinostatOxidative StressMitochondriaNeuroinflammatory DiseasesAnimalsMiceFemaleHistone Deacetylase InhibitorsMice, Inbred C57BLMyeloid Differentiation Factor 88MicrogliaToll-Like Receptor 2Spinal CordOligodendrogliaAstrocytesDisease Models, AnimalMultiple Sclerosis

Stichwörter der Autor:innen

experimental autoimmune encephalomyelitismitochondrial dysfunctionmultiple sclerosisneuroinflammationoxidative stresspanobinostat

Substanzen

PanobinostatHistone Deacetylase InhibitorsMyeloid Differentiation Factor 88Toll-Like Receptor 2Tlr2 protein, mouseMyd88 protein, mouse

Autor:innen und Institutionen

  • Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

ORCID-Profile: Li Li

Förderung

  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences
  • Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences
  • Major Scientific and Technological Special Project for "Significant New Drug Creation"
  • Major Scientific and Technological Special Project for “Significant New Drug Creation”

Zitieren

APA

Shen, Y., Zhao, J., Yang, R., Yang, H., Guo, M., Ji, B., Du, G., & Li, L. (2024). Panobinostat Attenuates Experimental Autoimmune Encephalomyelitis in Mice via Suppressing Oxidative Stress-Related Neuroinflammation and Mitochondrial Dysfunction. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212035

Vancouver

Shen Y, Zhao J, Yang R, Yang H, Guo M, Ji B, et al. Panobinostat Attenuates Experimental Autoimmune Encephalomyelitis in Mice via Suppressing Oxidative Stress-Related Neuroinflammation and Mitochondrial Dysfunction. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212035

BibTeX
@article{Shen2024,
  author = {Shen, Yanjia and Zhao, Jiaying and Yang, Ran and Yang, Huilin and Guo, Minmin and Ji, Baixi and Du, Guanhua and Li, Li},
  title = {Panobinostat Attenuates Experimental Autoimmune Encephalomyelitis in Mice via Suppressing Oxidative Stress-Related Neuroinflammation and Mitochondrial Dysfunction},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252212035}
}
Kostenlos starten →